Skip to main content
Smart Investors Daily
TC

NASDAQ · TCMD

Tactile Systems Technology, Inc.

Healthcare · Medical - Devices

$22.32

Up+$0.30 (+1.36%)

Updated Sep 11, 2026, 10:06 AM

SID Score

3.5/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
630.31M
P/E ratio
43.12
Dividend yield
0.00%
52-week range
$20.53 – $32.44
Volume
221.99K
Avg. volume
371.72K

Price performance

TCMD price history

1M range · 20 trading sessions · Daily adjusted prices

TCMD closed at $22.32 after 20 trading sessions, down 5.86% for the selected period.

Last close
$22.32
Period change
-5.86%
Period low
$21.73
Period high
$24.59
Daily close
View OHLC price history
TCMD OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 10, 2026$21.79$22.345$21.64$22.32221.99K
Sep 9, 2026$21.56$22.165$21.405$22.02317.82K
Sep 8, 2026$21.54$21.928$21.2894$21.73397.16K
Sep 4, 2026$21.76$22.26$21.615$21.87197.93K
Sep 3, 2026$22.50$22.9651$21.85$22.01340.07K
Sep 2, 2026$22.46$23.07$22.30$22.41310.35K
Sep 1, 2026$22.91$23.015$22.19$22.25302.63K
Aug 31, 2026$22.93$23.40$22.815$22.98278.32K
Aug 28, 2026$23.26$23.33$22.73$23.16304.58K
Aug 27, 2026$23.30$23.74$23.01$23.11203.26K
Aug 26, 2026$23.58$23.60$23.10$23.51206.8K
Aug 25, 2026$23.60$23.82$23.07$23.58329.72K
Aug 24, 2026$23.98$24.135$22.955$23.36286.49K
Aug 21, 2026$23.57$23.94$23.15$23.82356.5K
Aug 20, 2026$23.43$23.90$23.03$23.43378.51K
Aug 19, 2026$23.89$24.67$23.41$23.60395.08K
Aug 18, 2026$24.15$24.90$23.80$23.85729.99K
Aug 17, 2026$24.04$24.635$23.345$24.59306.33K
Aug 14, 2026$23.56$24.27$23.32$24.20364.5K
Aug 13, 2026$24.55$24.735$23.59$23.71507.49K

Latest TCMD news

The latest Smart Investors Daily articles mentioning TCMD.

TCMD research

Overview

Company profile and research snapshot.

Company profile

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$26.67
Implied upside
Analysts
11
TCMD recent ratings
DateFirmRatingTarget
Aug 11, 2026BTIGBuy
May 21, 2026BTIGBuy
May 7, 2026B. Riley SecuritiesBuy
May 5, 2026BTIGBuy
Feb 18, 2026B. Riley SecuritiesNeutral
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.